Edison Liu, president and CEO of The Jackson Laboratory TO SPEAK AT MIDDLESEX CHAMBER’S MAY BREAKFAST

This event, sponsored by Farmington Bank, will be held at the Radisson Hotel Cromwell, with networking beginning at 7:00 a.m., breakfast buffet at 7:30 a.m., and meeting program 8:00-9:00 a.m.
The
Jackson Laboratory is an independent, nonprofit organization focusing
on mammalian genetics research to advance human health. Their mission is
to discover precise genomic solutions for disease and empower the
global biomedical community in the shared quest to improve human health.
The
Jackson Laboratory's research institute in Connecticut is transforming
medicine by improving care, lowering costs, and increasing life span and
health span. Scientists in Connecticut research the complex genetic
causes of disease and develop genomic solutions tailored to each
person's unique genetic makeup.
The
Jackson Laboratory for Genomic Medicine draws on the Laboratory’s eight
decades of research in mammalian genetics in partnership with the
clinical expertise of Connecticut’s universities and hospitals. JAX
Genomic Medicine sits on a 17-acre site on the campus of the University
of Connecticut Health Center in Farmington, Conn. The
183,500-square-foot facility opened in the fall of 2014. Within 10 years,
it will house 300 biomedical researchers, technicians and support staff
in state-of-the-art computing facilities and laboratories.
Chamber
President Larry McHugh noted, “Our chamber supported this major
economic development and research initiative for our state, and we look
forward to hearing Dr. Liu’s remarks about the progress they are making
in Farmington. I would like to thank him for visiting with our group,
and Farmington Bank for sponsoring the event.”
ABOUT EDISON T. LIU, M.D.
Dr.
Liu is the president and CEO of The Jackson Laboratory. Previously, he
was the founding executive director of the Genome Institute of Singapore
(2001-2011), and was the president of the Human Genome Organization
(HUGO) from 2007-2013. Between 1997 and 2001, he was the scientific
director of the National Cancer Institute's Division of Clinical
Sciences in Bethesda, Md., where he was in charge of the intramural
clinical translational science programs.
From
1987 to 1996, Dr. Liu was a faculty member at the University of North
Carolina at Chapel Hill, where he was the director of the UNC Lineberger
Comprehensive Cancer Center's Specialized Program of Research
Excellence in Breast Cancer; the director of the Laboratory of Molecular
Epidemiology at UNC's School of Public Health; chief of Medical
Genetics; and the chair of the Correlative Science Committee of the
national cooperative clinical trials group, CALGB. Dr. Liu is an
international expert in cancer biology, genomics, human genetics,
molecular epidemiology and translational medicine.
No comments:
Post a Comment
Authors of comments and posts are solely responsible for their statements. Please email MiddletownInsider@gmail.com for questions or concerns. This blog, (and any site using the blogger platform), does not and cannot track the source of comments. While opinions and criticism are fine, they are subject to moderator discretion; slander and vile attacks of individuals will not to be tolerated. Middletown Insider retains the right to deny any post or comment without explanation.